Medicine, Hepatology Division — Northwestern Scholars

Heimbach, J. K., Kulik, L. M., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H. & Marrero, J. A., Jan 1 2018, In : Hepatology. 67, 1, p. 358-380 23 p.

Research output: Contribution to journal › Article

Liver Neoplasms

Hepatocellular Carcinoma

Guidelines

2 Citations

Acute Liver Failure of Indeterminate Etiology: A Comprehensive Systematic Approach by An Expert Committee to Establish Causality

for the Acute Liver Failure Study Group, Jun 27 2018, (Accepted/In press) In : American Journal of Gastroenterology. p. 1-10 10 p.

Research output: Contribution to journal › Article

Acute Liver Failure

Acetaminophen

Causality

Chemical and Drug Induced Liver Injury

Metagenomics

Grants 2002 2022

66 Active
159 Finished

Prot# EDP 305-101: A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects with Non-alcoholic Steatohepatitis (NASH)

Rinella, M. E.

ICON Clinical Research, LLC, Enanta Pharmaceuticals, Inc.

9/11/18 → 9/12/21

Project: Research project

Prot# C928-010: An Open- Label, Dose Escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamic Signals of DUR-928 in Patients with Alcoholic Hepatitis

Flamm, S. L.

CTI Clinical Trial and Consulting Services, DURECT Corporation

8/30/18 → 8/30/21

Project: Research project

Prot#GS-US-454-4378: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib, GS-0976, GS-9674, and Combinations in Subjects with Bridging (F3) Fibrosis or Compensated Cirrhosis (F4) due to Nonalcoho

Rinella, M. E.

PRA Health Sciences, Gilead Sciences, Inc.

8/23/18 → 8/23/21

Project: Research project